{
  "primary": "FUS",
  "interaction_type": "indirect",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Similar to its role with TDP-43, VCP is directly involved in the disaggregation and clearance of FUS (Fused in Sarcoma) protein aggregates, which are implicated in neurodegenerative diseases.",
  "functions": [
    {
      "function": "FUS Aggregate Clearance",
      "arrow": "activates",
      "cellular_process": "VCP is involved in maintaining the proteostasis of FUS, an RNA-binding protein also prone to aggregation in neurodegenerative diseases. VCP-mediated turnover of FUS is linked to the endo-lysosomal pathway. By processing ubiquitinated FUS, VCP facilitates its clearance, preventing its toxic cytoplasmic accumulation and mislocalization. VCP mutations disrupt this process, leading to FUS pathology.",
      "effect_description": "VCP promotes the turnover and clearance of the aggregation-prone FUS protein, thereby reducing its cellular toxicity. This function is analogous to its role with TDP-43 and is critical for neuronal health.",
      "biological_consequence": [
        "Cytoplasmic FUS aggregates or mislocalizes → FUS becomes ubiquitinated, signaling for degradation → VCP recognizes and processes ubiquitinated FUS → VCP facilitates FUS turnover, potentially through an endocytosis-dependent mechanism → Degradation of FUS in lysosomes mitigates its toxic effects."
      ],
      "specific_effects": [
        "Mutations in VCP lead to the nuclear-to-cytoplasmic mislocalization of FUS in human motor neurons.",
        "The turnover and toxicity of FUS are regulated by VCP and are dependent on endocytic function.",
        "A direct physical interaction between VCP and FUS has been described."
      ],
      "evidence": [
        {
          "paper_title": "Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover",
          "journal": "Molecular and Cellular Biology",
          "year": 2020,
          "relevant_quote": "Taken together, our data identify a role for Cdc48/VCP and endocytic function in regulating TDP-43 and FUS toxicity and turnover. Furthermore, endocytic dysfunction may be a common defect affecting the cytoplasmic clearance of ALS aggregation-prone proteins and may represent a novel therapeutic target of promise.",
          "pmid": "31767634"
        },
        {
          "paper_title": "TDP-43 and FUS mislocalization in VCP mutant motor neurons is reversed by pharmacological inhibition of the VCP D2 ATPase domain",
          "journal": "Brain Communications",
          "year": 2021,
          "relevant_quote": "We reveal that TDP-43, FUS and SFPQ exhibit reduced nuclear-to-cytoplasmic ratios in the VCP mutant MNs... Importantly, we find that in VCP mutant MNs the nuclear-to-cytoplasmic mislocalization of both TDP-43 and FUS... are reversible by treatment with a pharmacological inhibitor of the VCP D2 ATPase domain.",
          "pmid": "34396115"
        }
      ],
      "pathway": {
        "name": "Aggrephagy",
        "canonical_name": "Aggrephagy",
        "ontology_id": "GO:0035973",
        "ontology_source": "GO",
        "confidence": 0.8
      },
      "pmids": [
        "31767634",
        "34396115"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "main_to_primary",
      "function_effect": "activation",
      "arrow_context": {
        "direct_from": null,
        "direct_arrow": "activates",
        "net_from": "VCP",
        "net_arrow": "activates",
        "mediator_chain": [],
        "is_indirect": true
      },
      "net_arrow": "activates",
      "direct_arrow": "activates",
      "net_effect": "activation",
      "direct_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "VCP is involved in maintaining the proteostasis of FUS, an RNA-binding protein also prone to aggregation in neurodegenerative diseases. VCP-mediated turnover of FUS is linked to the endo-lysosomal pathway. By processing ubiquitinated FUS, VCP facilitates its clearance, preventing its toxic cytoplasmic accumulation and mislocalization. VCP mutations disrupt this process, leading to FUS pathology.",
  "effect": "VCP promotes the turnover and clearance of the aggregation-prone FUS protein, thereby reducing its cellular toxicity. This function is analogous to its role with TDP-43 and is critical for neuronal health.",
  "summary": "VCP activates FUS to modulate fus aggregate clearance, ultimately affecting degradation of fus in lysosomes mitigates its toxic effects.",
  "evidence": [
    {
      "paper_title": "Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover",
      "journal": "Molecular and Cellular Biology",
      "year": 2020,
      "relevant_quote": "Taken together, our data identify a role for Cdc48/VCP and endocytic function in regulating TDP-43 and FUS toxicity and turnover. Furthermore, endocytic dysfunction may be a common defect affecting the cytoplasmic clearance of ALS aggregation-prone proteins and may represent a novel therapeutic target of promise."
    },
    {
      "paper_title": "TDP-43 and FUS mislocalization in VCP mutant motor neurons is reversed by pharmacological inhibition of the VCP D2 ATPase domain",
      "journal": "Brain Communications",
      "year": 2021,
      "relevant_quote": "We reveal that TDP-43, FUS and SFPQ exhibit reduced nuclear-to-cytoplasmic ratios in the VCP mutant MNs... Importantly, we find that in VCP mutant MNs the nuclear-to-cytoplasmic mislocalization of both TDP-43 and FUS... are reversible by treatment with a pharmacological inhibitor of the VCP D2 ATPase domain."
    }
  ],
  "pathways": [
    {
      "name": "Aggrephagy",
      "canonical_name": "Aggrephagy",
      "ontology_id": "GO:0035973",
      "ontology_source": "GO",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "VCP --regulates--> FUS:",
  "protein_a": "VCP",
  "protein_b": "FUS",
  "discovered_in_query": "VCP",
  "first_discovered": "2025-12-06T04:46:06.387348Z",
  "last_updated": "2025-12-06T04:46:06.387348Z"
}